MobiHealth News October 18, 2021
The market is forecast to reach $9.13 billion (€7.84 billion) by 2026.
A new report from Research2Guidance discusses the rise in digital decentralised clinical trial (DDCT) technologies since the COVID-19 pandemic.
Digital solutions for decentralised clinical trials allow some or all clinical trial activities to be conducted virtually rather than in person. This includes technology such as wearables to continuously collect patient data, telemedicine to deliver education and consent, and software dashboards to track patient data.
The Digital Decentralized Clinical Trials Solutions Market, 2018-2026 report explores the proposed benefits of these technologies and long-term trends that will continue to shape the market.
It also examines industry claims that DDCT solutions can enable an overall faster recruitment process, higher diversity of...
Today's Sponsors
Today's Sponsor